Latest News

01.10.19

EMA Handed Down Fewer Positive Drug Opinions in 2018

Source: Medscape

01.09.19

FDA Approved Record Number of Drugs in 2018

Source: Medscape

01.07.19

Oculogica Receives FDA Marketing Approval for EyeBOX, the First Noninvasive, Baseline-Free Test for Concussion

Source: Oculogica

01.03.19

Bausch + Lomb Announces Health Canada Approval Of Vyzulta for the Treatment of Glaucoma

Source: Bausch + Lomb

01.03.19

EyePoint Pharmaceuticals to Launch Dexycu and Yutiq in First Quarter of 2019

Source: EyePoint Pharmaceuticals

12.12.18

RayOne Aspheric Fully Preloaded IOL Receives FDA Clearance

Source: Rayner

12.10.18

Ophthalmic Investment Funds Led by Retinal Gene Therapy Developers

Source: Market Scope

12.10.18

Santen Announces Scottish Medicines Consortium Approval of Verkazia for Severe Vernal Keratoconjunctivitis

Source: Santen

12.03.18

Ocular Therapeutix Announces FDA Approval of Dextenza for the Treatment of Ocular Pain Following Ophthalmic Surgery

Source: Ocular Therapeutix

10.27.18

Zeiss Introduces New Advances in Astigmatism Management and Glaucoma Imaging at AAO

Source: Zeiss

View more stories